Customize your JAMA Network experience by selecting one or more topics from the list below.
Numerous reports have attested to the efficacy of streptomycin in the treatment of cutaneous tuberculosis.1 However, its beneficial action, for the most part, has been observed only in certain types of involvement, namely cutaneous sinuses and fistulas. A review of the literature discloses only two cases of tuberculosis verrucosa cutis treated with streptomycin. The first was included in a report by Combes, Canizares, Shatin and Kaufman,1f and the second was more recently presented by Allison, Robinson and Frutchey.2 In both cases 1 Gm. of streptomycin was given daily for six weeks with rapid involution of the lesions. This report concerns a third patient with tuberculosis verrucosa cutis successfully treated with streptomycin.
REPORT OF A CASE
M. C., a 35 year old white woman, gave a history of hoarseness and cough of several months' duration. Roentgenologic studies showed evidence of moderately advanced pulmonary tuberculosis, confirmed by the finding of tubercle bacilli in her sputum. On her left hand were several
KERN AB. TUBERCULOSIS VERRUCOSA CUTIS TREATED WITH STREPTOMYCIN. AMA Arch Derm Syphilol. 1951;63(3):378–380. doi:10.1001/archderm.1951.01570030092013
Coronavirus Resource Center
Create a personal account or sign in to: